Steven Shak, Chief Scientific Officer at GENOMIC HEALTH INC (GHDX), sold 5,000 shares at $29.40 ($147K) on 2017-05-23, disclosed to the SEC on 2017-05-25.
Scheduled sale ($147k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| GHDX | SELL | 2019-08-05 | $3.6M | — | Filing → |
| GHDX | SELL | 2019-07-10 | $2.8M | — | Filing → |
| GHDX | SELL | 2019-06-17 | $3.7M | — | Filing → |